# Brian Angus

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/brian-angus/

## Facts

| Field | Value |
| --- | --- |
| Citations | 31,094 |
| Field | Malaria Research and Control |
| h-index | 75 |
| i10-index | 201 |
| Last Known Institution | Churchill Hospital |
| OpenAlex ID | https://openalex.org/A5006623516 |
| ORCID iD | https://orcid.org/0000-0003-3598-7784 |
| Works | 366 |

## Researcher papers

- [Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK](https://scholariq.org/papers/safety-and-efficacy-of-the-chadox1-ncov-19-vaccine-azd1222-against-sars-cov-2-an/)
- [Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial](https://scholariq.org/papers/safety-and-immunogenicity-of-the-chadox1-ncov-19-vaccine-against-sars-cov-2-a/)
- [Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials](https://scholariq.org/papers/single-dose-administration-and-the-influence-of-the-timing-of-the-booster-dose/)
- [Oral versus Intravenous Antibiotics for Bone and Joint Infection](https://scholariq.org/papers/oral-versus-intravenous-antibiotics-for-bone-and-joint-infection/)
- [T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1/2 clinical trial](https://scholariq.org/papers/t-cell-and-antibody-responses-induced-by-a-single-dose-of-chadox1-ncov-19/)
- [Medium-term effects of SARS-CoV-2 infection on multiple vital organs, exercise capacity, cognition, quality of life and mental health, post-hospital discharge](https://scholariq.org/papers/medium-term-effects-of-sars-cov-2-infection-on-multiple-vital-organs-exercise/)
- [Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses](https://scholariq.org/papers/phase-1-2-trial-of-sars-cov-2-vaccine-chadox1-ncov-19-with-a-booster-dose/)
- [p53 Mutations Are Common and Early Events that Precede Tumor Invasion in Squamous Cell Neoplasia of the Skin](https://scholariq.org/papers/p53-mutations-are-common-and-early-events-that-precede-tumor-invasion-in/)
- [Red blood cell deformability as a predictor of anemia in severe falciparum malaria.](https://scholariq.org/papers/red-blood-cell-deformability-as-a-predictor-of-anemia-in-severe-falciparum/)

## Researcher topics

- [Malaria Research and Control](https://scholariq.org/topics/malaria-research-and-control/)
- [Lymphoma Diagnosis and Treatment](https://scholariq.org/topics/lymphoma-diagnosis-and-treatment/)
- [Salmonella and Campylobacter epidemiology](https://scholariq.org/topics/salmonella-and-campylobacter-epidemiology/)
- [Mosquito-borne diseases and control](https://scholariq.org/topics/mosquito-borne-diseases-and-control/)
- [SARS-CoV-2 and COVID-19 Research](https://scholariq.org/topics/sars-cov-2-and-covid-19-research/)

## Researcher university

- [Churchill Hospital](https://scholariq.org/institutions/churchill-hospital/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.